| According
to this explanation, a three-year study determined that patients
who took Vioxx had a greater risk for heart attack and
stroke. Because Ceoxx is the "other" brand name
for Vioxx outside of the United States, the same applies to
ceoxx side effects.
"WHITEHOUSE STATION, N.J.,
Sept. 30, 2004—Merck & Co., Inc. today announced a
voluntary worldwide withdrawal of VIOXX® (rofecoxib), its
arthritis and acute pain medication. The company’s decision,
which is effective immediately, is based on new, three-year data
from a prospective, randomized, placebo-controlled clinical
trial, the APPROVe (Adenomatous Polyp Prevention on VIOXX)
trial."
"The trial, which is being
stopped, was designed to evaluate the efficacy of VIOXX 25 mg in
preventing recurrence of colorectal polyps in patients with a
history of colorectal adenomas. In this study, there was an
increased relative risk for confirmed cardiovascular events,
such as heart attack and stroke, beginning after 18 months of
treatment in the patients taking VIOXX compared to those taking
placebo. The results for the first 18 months of the APPROVe
study did not show any increased risk of confirmed
cardiovascular events on VIOXX, and in this respect, are similar
to the results of two placebo-controlled studies described in
the current U.S. labeling for VIOXX."--http://www.drug-warnings.com/ceoxx.htm
Vioxx Lawsuit
Autism
Education Materials!
|
|
